COMPARISON OF PREGNANCY OUTCOME IN OOCYTE RECIPIENTS AFTER GNRH ANTAGONIST TREATMENT IN THE PROLIPHERATIVE PHASE

COMPARISON OF PREGNANCY OUTCOME IN OOCYTE RECIPIENTS AFTER GNRH ANTAGONIST TREATMENT IN THE PROLIPHERATIVE PHASE - PREGNANCY RATES AFTER GNRH ANTAGONIST ADMINISTRATION

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001051

Enrollment

Registered

2008-02-25

Start date

2004-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IN VITRO FERTILIZATION CYCLES

Interventions

TREATMENT WITH GNRH ANTAGONIST NO TREATMENT

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: MENOPAUSAL WOMEN, AT LEAST 6 OOCYTES FROM THE DONOR TO PROCEED WITH IVF CYCLES

Exclusion criteria

Exclusion criteria: THREE PREVIOUS FAILED ivf CYCLES, UTERINE MALFORMATION,

Design outcomes

Primary

Measure	Time frame
PREGNANCY RATES	—

Secondary

Measure	Time frame
IMPLANTATION RATES, MISCARRIAGE RATES, ENDOMETRIAL THICKNESS	—

Countries

Europe

Contacts

Public ContactASIMINA TAVANIOTOU

IAKENTRO FERTILITY CENTRE PRIVATE FERTILITY CENTRE

mtavaniotou@hotmail.com+302310325525

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026